{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:07:40Z","timestamp":1769116060580,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.cjca.2016.05.008","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T23:03:16Z","timestamp":1463180596000},"page":"1166.e1-1166.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging"],"prefix":"10.1016","volume":"32","author":[{"given":"David L.","family":"Narotsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Castano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan W.","family":"Weinsaft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabahat","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2016.05.008_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","article-title":"Cardiac amyloidosis: the great pretender","volume":"20","author":"Rapezzi","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2016.05.008_bib2","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"issue":"suppl 2","key":"10.1016\/j.cjca.2016.05.008_bib3","first-page":"29","article-title":"Infiltrative cardiomyopathies","volume":"9","author":"Bejar","year":"2015","journal-title":"Clin Med Insights Cardiol"},{"key":"10.1016\/j.cjca.2016.05.008_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCIMAGING.113.001396","article-title":"How to image cardiac amyloidosis","volume":"7","author":"Falk","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2016.05.008_bib5","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.acvd.2013.06.051","article-title":"Cardiac amyloidosis: updates in diagnosis and management","volume":"106","author":"Mohty","year":"2013","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2016.05.008_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/13506129.2015.1051219","article-title":"Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14\u2009333 African-Americans","volume":"22","author":"Jacobson","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.cjca.2016.05.008_bib7","doi-asserted-by":"crossref","first-page":"e000364","DOI":"10.1161\/JAHA.111.000364","article-title":"Updates in cardiac amyloidosis: a review","volume":"1","author":"Banypersad","year":"2012","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2016.05.008_bib8","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2016.05.008_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2016.05.008_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12350-013-9800-5","article-title":"Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques","volume":"21","author":"Aljaroudi","year":"2014","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.cjca.2016.05.008_bib11","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ehjci\/jeu158","article-title":"The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease","volume":"15","author":"Di Bella","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2016.05.008_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ahj.2012.04.015","article-title":"Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS)","volume":"64","author":"Ruberg","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2016.05.008_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","article-title":"Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective, observational cohort study","volume":"133","author":"Connors","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.05.008_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.cjca.2016.05.008_bib15","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2016.05.008_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","article-title":"Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs","volume":"20","author":"Castano","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2016.05.008_bib17","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.63.6.1285","article-title":"Digoxin sensitivity in amyloid cardiomyopathy","volume":"63","author":"Rubinow","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.05.008_bib18","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.05.008_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.amjcard.2014.07.026","article-title":"Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis","volume":"114","author":"Cyrille","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2016.05.008_bib20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0895-7061(02)02945-X","article-title":"Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE Study","volume":"15","author":"Okin","year":"2002","journal-title":"Am J Hypertens"},{"issue":"13 suppl 1","key":"10.1016\/j.cjca.2016.05.008_bib21","doi-asserted-by":"crossref","first-page":"E1586","DOI":"10.1016\/S0735-1097(12)61587-3","article-title":"A\u00a0simple voltage\/mass index improves diagnosis of cardiac amyloidosis: an electrocardiographic and echocardiographic study of 570 patients with left ventricular hypertrophy (abstract)","volume":"59","author":"Quarta","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2016.05.008_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12350-013-9803-2","article-title":"Nuclear imaging modalities for cardiac amyloidosis","volume":"21","author":"Bokhari","year":"2014","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.cjca.2016.05.008_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.proghi.2012.03.001","article-title":"On typing amyloidosis using immunohistochemistry: detailed illustrations, review and a note on mass spectrometry","volume":"47","author":"Linke","year":"2012","journal-title":"Prog Histochem Cytochem"},{"key":"10.1016\/j.cjca.2016.05.008_bib24","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1540-8175.2012.01680.x","article-title":"Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocardiography","volume":"29","author":"Baccouche","year":"2012","journal-title":"Echocardiography"},{"key":"10.1016\/j.cjca.2016.05.008_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/clc.22353","article-title":"Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis","volume":"38","author":"Cappelli","year":"2015","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjca.2016.05.008_bib26","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","article-title":"Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis","volume":"129","author":"Quarta","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.05.008_bib27","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","article-title":"Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated (AL) amyloidosis","volume":"165","author":"Ng","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2016.05.008_bib28","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1540-8175.2010.01344.x","article-title":"Can myocardial strain differentiate hypertrophic from infiltrative etiology of a thickened septum?","volume":"28","author":"Engvall","year":"2011","journal-title":"Echocardiography"},{"key":"10.1016\/j.cjca.2016.05.008_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCHEARTFAILURE.109.910455","article-title":"Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS)","volume":"4","author":"Bhuiyan","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2016.05.008_bib30","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1182\/blood.V126.23.1774.1774","article-title":"In patients with light-chain (AL) amyloidosis myocardial contraction fraction (MCF) is a simple, but powerful prognostic measure that can be calculated from a standard echocardiogram (ECHO) [abstract]","volume":"126","author":"Milani","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cjca.2016.05.008_bib31","first-page":"1","article-title":"The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis","volume":"16","author":"Tendler","year":"2014","journal-title":"Amyloid"},{"key":"10.1016\/j.cjca.2016.05.008_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0140-6736(77)91102-3","article-title":"Scanning for soft-tissue amyloid","volume":"1","author":"Kula","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2016.05.008_bib33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0002-8703(82)90344-1","article-title":"Noninvasive diagnosis of cardiac amyloidosis by technetium-99m-pyrophosphate myocardial scintigraphy","volume":"103","author":"Sobol","year":"1982","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2016.05.008_bib34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2016.05.008_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2016.05.008_bib36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of 99mTc-PYP scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","author":"Rapezzi","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2016.05.008_bib37","doi-asserted-by":"crossref","unstructured":"Casta\u00f1o A, DeLuca A, Weinberg R, et\u00a0al. Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis. J Nucl Cardiol, http:\/\/dx.doi.org\/10.1007\/s12350-015-0261-x, accessed May 5, 2016.","DOI":"10.1007\/s12350-015-0261-x"},{"key":"10.1016\/j.cjca.2016.05.008_bib38","doi-asserted-by":"crossref","first-page":"A13456","DOI":"10.1161\/circ.132.suppl_3.13456","article-title":"Screening for transthyretin cardiac amyloidosis using 99mTc-pyrophosphate scintigraphy in patients undergoing transcatheter aortic valve replacement [abstract]","volume":"132","author":"Narotsky","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.05.008_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","article-title":"Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy","volume":"90","author":"Grothues","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2016.05.008_bib40","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1148\/radiol.2482072016","article-title":"Left ventricle: automated segmentation by using myocardial effusion threshold reduction and intravoxel computation at MR imaging","volume":"248","author":"Codella","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.cjca.2016.05.008_bib41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/CIRCIMAGING.111.966754","article-title":"Improved left ventricular mass quantification with partial voxel interpolation: in\u00a0vivo and necropsy validation of a novel cardiac MRI segmentation algorithm","volume":"5","author":"Codella","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2016.05.008_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcmg.2013.09.019","article-title":"CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis","volume":"7","author":"White","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2016.05.008_bib43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2016.05.008_bib44","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jcmg.2009.08.008","article-title":"Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis","volume":"2","author":"Austin","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2016.05.008_bib45","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.05.008_bib46","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2016.05.008_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2016.05.008_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2016.05.008_bib49","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/joim.12324","article-title":"Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging","volume":"277","author":"Barison","year":"2015","journal-title":"J\u00a0Intern Med"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2016.05.008_bib50","doi-asserted-by":"crossref","first-page":"P341","DOI":"10.1186\/1532-429X-16-S1-P341","article-title":"AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology [abstract]","volume":"16","author":"Fontana","year":"2014","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.cjca.2016.05.008_bib51","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","article-title":"Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study","volume":"277","author":"Fontana","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.cjca.2016.05.008_bib52","unstructured":"ASNC Practice Points. 99mTechnetium-pyrophosphate imaging for transthyretin cardiac amyloidosis. Available at: http:\/\/www.asnc.org\/Files\/Practice%20Resources\/Practice%20Points\/ASNC%20Practice%20Point-99mTechnetiumPyrophosphateImaging2016.pdf. Accessed March 2, 2016."},{"key":"10.1016\/j.cjca.2016.05.008_bib53","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Non-biopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X16300915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X16300915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T20:29:43Z","timestamp":1655929783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X16300915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0828282X16300915"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2016.05.008","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2016.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}